<DOC>
	<DOCNO>NCT01022242</DOCNO>
	<brief_summary>The objective study assess efficacy , safety , handle PXL01 patient flexor tendon injury zone I II .</brief_summary>
	<brief_title>Study PXL01 Versus Placebo Inhibit Adhesion Formation After Flexor Tendon Surgery</brief_title>
	<detailed_description>This multi-centre , randomize , double blind , parallel study design patient admit flexor tendon repair zone II . The patient undergo 9 visit within time frame study . Patients randomize receive treatment PXL01 standard care . Primary objective ass total active motion base PIP DIP joint ( TAM2 ) 12-week visit . Secondary objective ass TAM2 time point except 12 week , TAM base MCP , PIP , DIP joint ( TAM3 ) time point , Total Active Motion DIP joint ( DIPAM ) , tip-to-crease , grip strength Total Passive Motion ( TPM2 TPM3 ) . Before study-related assessment take place , patient give verbal write information study inform consent achieve patient and/or legal guardian . The study carry accordance Clinical Study Protocol ( CSP ) , ICH guideline Good Clinical Practise ( GCP ) , applicable regulatory requirement .</detailed_description>
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Inclusion criterion : 1 . Complete division flexor digitorium profundus tendon ( FDP ) zone I II , without division flexor digitorium superficialis ( FDS ) possible rejoin tendon suture 2 . Open flexor tendon injury suture within 14 day trauma 3 . 1275 year age 4 . Signed informed consent prior study related procedure Exclusion criterion 1 . Treatment investigational product within 4 week study entry 2 . Patients previously include study 3 . Thumbs complete partial division flexor pollicis longus ( FPL ) 4 . Concomitant fracture ( ) require immobilisation 5 . Injuries associate soft tissue loss 6 . Severe crush injury 7 . Palmar plate injury require immobilisation 8 . Devascularisation/requirement vascular repair 9 . Joint injury 10 . Bilateral injury 11 . Previous flexor tendon surgery digit , treat IMP 12 . Reduced motion digit , treat IMP , correspond digit prior injury 13 . Compliance mobilisation protocol expect 14 . Alcohol drug abuse 15 . Severe intercurrent illness , opinion Investigator , may put patient risk participate study , affect patient 's ability take part study 16 . Pregnant lactating female 17 . Fertile woman accept consistent correct use highly effective method birth control define implant , injectables , combine oral contraceptive , intrauterine device ( IUD ) , sexual abstinence vasectomise partner first two week postsurgery . A condom alone consider acceptable method birth control , even together spermicide . 18 . Known allergy component study product placebo 19 . Patients suffer : Diabetes Mellitus patient significant diabetic complication may delay heal accord investigator 's judgement Rheumatoid arthritis 20 . Or patient treat : Systemic steroid within one month Immunosuppressive drug within three month Daily use NSAIDs within one week occasional use within 8 hour</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Surgical Adhesions</keyword>
	<keyword>Post-surgical adhesion</keyword>
	<keyword>Flexor tendon</keyword>
</DOC>